Clinical trial · Observational
Application of LARS Ligament in Bone Prosthesis Replacement
A Prospective, Real-world, Single-center, Cohort Study of LARS Ligaments in Bone Tumors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a single-center, prospective, real-world observational study designed to enroll all patients eligible for enrollment. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Tumor | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| LARS ligament and bone prosthesis replacement was performed | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- LARS ligament and bone prosthesis replacement was performed
- description
- To report the postoperative complications and limb function of patients who underwent LARS ligament and bone prosthesis replacement in Henan Cancer Hospital.
- interventionNames
- Other: LARS ligament and bone prosthesis replacement was performed
Primary outcomes (2)
- measure
- Postoperative complications
- timeFrame
- From surgery to 24 months after surgery
- description
- Complications of patients undergoing LARS ligament and bone prosthesis replacement.
- measure
- Limb function
- timeFrame
- Patients were enrolled until 24 months after surgery
- description
- Limb function was assessed using the Musculoskeletal Oncology Society (MSTS) scoring scale for seven items, namely movement, pain, stability, deformity, strength, functional activity, and emotional receptiveness. The highest possible score is 35, with 5 points allocated to each project.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Men and women of all ages are welcome. Pathologically confirmed in our hospital as a subtype of malignant tumor. He received LARS ligament and bone prosthesis replacement at our hospital. Exclusion Criteria: Not Applicable.
References
Publications (0)
Data not yet available